A carregar...

Disease-Modifying Effects of M(1) Muscarinic Acetylcholine Receptor Activation in an Alzheimer’s Disease Mouse Model

Alzheimer’s disease (AD) is the leading cause of dementia worldwide, and currently no disease-modifying therapy is available to slow or prevent AD, underscoring the urgent need for neuroprotective therapies. Selective M(1) muscarinic acetylcholine receptor (mAChR) activation is an attractive mechani...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACS Chem Neurosci
Main Authors: Lebois, Evan P., Schroeder, Jason P., Esparza, Thomas J., Bridges, Thomas M., Lindsley, Craig W., Conn, P. Jeffrey, Brody, David L., Daniels, J. Scott, Levey, Allan I.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808561/
https://ncbi.nlm.nih.gov/pubmed/28230352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.6b00278
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!